Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
CG Oncology, Inc.
Scientific Title
A Phase 3 Study of CG0070 in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus-Calmette-Guerin (BCG)